Evidence map›Paper›PMID 37717111›Full record

ArticleScientific reports2023

Enhancing protein trapping efficiency of graphene oxide-polybutylene succinate nanofiber membrane via molecular imprinting.

Nuankanya Sathirapongsasuti, Anuchan Panaksri, Benjabhorn Jusain, Sani Boonyagul, Suejit Pechprasarn, Kittisak Jantanasakulwong, Acharee Suksuwan, Somprasong Thongkham, Nuttapol Tanadchangsaeng

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Nuankanya SathirapongsasutiProgram in Translational Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Ratchathewi, Bangkok, Thailand.
Anuchan PanaksriCollege of Biomedical Engineering, Rangsit University, Lak Hok, Pathumthani, Thailand.
Benjabhorn JusainCollege of Biomedical Engineering, Rangsit University, Lak Hok, Pathumthani, Thailand.
Sani BoonyagulCollege of Biomedical Engineering, Rangsit University, Lak Hok, Pathumthani, Thailand.
Suejit PechprasarnCollege of Biomedical Engineering, Rangsit University, Lak Hok, Pathumthani, Thailand.
Kittisak JantanasakulwongSchool of Agro-Industry, Faculty of Agro-Industry, Chiang Mai University, Mae Hia, Chiang Mai, Thailand.
Acharee SuksuwanThe Halal Science Center, Chulalongkorn University, Pathum Wan, Bangkok, Thailand.
Somprasong ThongkhamNational Nanotechnology Center (NANOTEC), National Science and Technology Development Agency (NSTDA), Klong Luang, Pathumthani, Thailand.
Nuttapol TanadchangsaengCollege of Biomedical Engineering, Rangsit University, Lak Hok, Pathumthani, Thailand. nuttapol.t@rsu.ac.th.
Rangsit University · THChiang Mai University · THChulalongkorn University · THNational Nanotechnology Center · THRamathibodi Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Filtration of biological liquids has been widely employed in biological, medical, and environmental investigations due to its convenience; many could be performed without energy and on-site, particularly protein separation. However, most available membranes are universal protein absorption or sub-fractionation due to molecule sizes or properties. SPMA, or syringe-push membrane absorption, is a quick and easy way to prepare biofluids for protein evaluation. The idea of initiating SPMA was to filter proteins from human urine for subsequent proteomic analysis. In our previous study, we developed nanofiber membranes made from polybutylene succinate (PBS) composed of graphene oxide (GO) for SPMA. In this study, we combined molecular imprinting with our developed PBS fiber membranes mixed with graphene oxide to improve protein capture selectivity in a lock-and-key fashion and thereby increase the efficacy of protein capture. As a model, we selected albumin from human serum (ABH), a clinically significant urine biomarker, for proteomic application. The nanofibrous membrane was generated utilizing the electrospinning technique with PBS/GO composite. The PBS/GO solution mixed with ABH was injected from a syringe and transformed into nanofibers by an electric voltage, which led the fibers to a rotating collector spinning for fiber collection. The imprinting process was carried out by removing the albumin protein template from the membrane through immersion of the membrane in a 60% acetonitrile solution for 4 h to generate a molecular imprint on the membrane. Protein trapping ability, high surface area, the potential for producing affinity with proteins, and molecular-level memory were all evaluated using the fabricated membrane morphology, protein binding capacity, and quantitative protein measurement. This study revealed that GO is a controlling factor, increasing electrical conductivity and reducing fiber sizes and membrane pore areas in PBS-GO-composites. On the other hand, the molecular imprinting did not influence membrane shape, nanofiber size, or density. Human albumin imprinted membrane could increase the PBS-GO membrane's ABH binding capacity from 50 to 83%. It can be indicated that applying the imprinting technique in combination with the graphene oxide composite technique resulted in enhanced ABH binding capabilities than using either technique individually in membrane fabrication. The suitable protein elution solution is at 60% acetonitrile with an immersion time of 4 h. Our approach has resulted in the possibility of improving filter membranes for protein enrichment and storage in a variety of biological fluids.

Indexed as

Molecular ImprintingNanofibersAcetonitrilesAlbuminsButylene GlycolsGraphiteHumansPolymersProteomicsacetonitrileAcetonitrilesAlbuminsbionoleButylene Glycolsgraphene oxideGraphitePolymers

Identifiers

PMID37717111
PMCPMC10505162
OpenAlexW4386800687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.